Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Aging-Related Muscle Bmal1 Decline Contributes to Bone Loss in Mice via Enhancing IL-1α-Mediated Osteoclastogenesis

Huang K., Qian J., Wang Y., Zhang F., Xu Y., Zhai Q.

Animal Study on Systemic / IV, published in Aging Cell (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Aging Cell (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42259765
PMCID
PMC13246325
DOI
10.1111/acel.70582

Abstract (original English)

Osteoporosis, a common metabolic bone disorder linked to aging, is often accompanied by muscle degeneration. Muscle Bmal1 disruption in mice has been shown to affect various tissues, including the kidney, lung, and bone, indicating that the muscle molecular clock may influence the physiological homeostasis of multiple organs through systemic circulation. Despite this, the role of the muscle clock in age-related osteoporosis remains unclear. In aged mice, we observed a disruption in the circadian interaction between muscle and bone. Furthermore, both Bmal1 expression within muscle fibers and total BMAL1 protein levels in muscle tissue were significantly reduced. Using skeletal muscle-specific Bmal1 knockout mice, we observed osteoporosis-related phenotypes, including decreased bone mass and disrupted trabecular microarchitecture, along with disrupted diurnal expression of inflammatory cytokines. Mechanistically, we revealed that muscle Bmal1 deficiency impairs the rhythmic expression of the Hmox1 and induces the upregulation of IL-1α in muscle cells. The elevated circulating IL-1α promotes osteoclast differentiation, ultimately reducing bone mass. Importantly, the osteoporosis-related phenotype resulting from muscle Bmal1 knockout or aging was alleviated by nighttime time-restricted feeding (TRF), which reestablished a feeding-driven diurnal variation in Hmox1 expression within

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Muscle, SkeletalOsteoclastsAnimalsMice, Inbred C57BLMice, KnockoutMiceOsteoporosisAgingOsteogenesisMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research